Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.65    -0.25 (-0.32%)
Bid:
78.45
Ask:
78.65
Spread: 0.20 (0.255%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Director/PDMR Shareholding

17 Mar 2025 14:00

RNS Number : 9823A
Coats Group PLC
17 March 2025
 

17 March 2025

Coats Group plc

Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Paja

 

2

Reason for the notification

a)

Position/status

Chief Executive Officer and Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

a)

Name

Coats Group plc

b)

LEI

2138003SPYWGAITNFY17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Share award constituting a right to acquire Ordinary shares of £0.05

 

GB00B4YZN328

 

b)

Nature of the transaction

1.

Award of nil cost share options under the terms of the Coats Group plc Deferred Annual Bonus Plan ("DABP") as set out below:

 

The DABP awards represent a proportion of the annual bonus awarded for the year ended 31 December 2024 and vest after 3 years from the date of the award. DABP awards are not subject to performance conditions, as the bonus targets in respect of 2024 have already been met, but awards are subject to certain forfeiture and clawback provisions in certain situations such as personal misconduct or a misstatement of results.

2.

Award of nil cost share options under the terms of the Coats Group plc Long Term Incentive Plan ("LTIP") the performance conditions are set out in the attached Appendix 1.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) DABP

2) LTIP

 Nil

 Nil

220,210

1,541,472

d)

Aggregated information

· - Aggregated volume

· - Price

 

1,761,682

n/a

e)

Date of the transaction

2025-03-14

 

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jacqueline Callaway

 

2

Reason for the notification

a)

Position/status

Chief Financial Officer and Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

a)

Name

Coats Group plc

b)

LEI

2138003SPYWGAITNFY17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Share award constituting a right to acquire Ordinary shares of £0.05

 

GB00B4YZN328

 

b)

Nature of the transaction

1.

Award of nil cost share options under the terms of the Coats Group plc Deferred Annual Bonus Plan ("DABP") as set out below:

 

The DABP awards represent a proportion of the annual bonus awarded for the year ended 31 December 2024 and vest after 3 years from the date of the award. DABP awards are not subject to performance conditions, as the bonus targets in respect of 2024 have already been met, but awards are subject to certain forfeiture and clawback provisions in certain situations such as personal misconduct or a misstatement of results.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) DABP

 Nil

290,375

d)

Aggregated information

· - Aggregated volume

· - Price

 

290,375

n/a

e)

Date of the transaction

2025-03-14

 

f)

Place of the transaction

Outside a trading venue

 

Enquiry details

 

Investors

Anjali Kotak

Coats Group plc

+44 (0)7880 471350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

Appendix 1

Coats Group plc - 2025 Long Term Incentive Award - Performance Schedule

Introduction

The following schedule sets out the performance conditions that will apply to the 2025 Coats Group PLC Long Term Incentive award. The performance period is 1 January 2025 to 31 December 2027.

 

Performance Measures & Weighting

The award has four performance measures and is weighted as set out below.

Measure

Weighting

(% of total award)

Definition1

 

Coats Group plc Earnings Per Share Compound Annual Growth (CAGR)

30%

The Compound Annual Growth (CAGR) in EPS achieved in the performance period. The Board will consider the CAGR in Normalised EPS which is EPS, adjusted to exclude exceptional items such as property gains or losses and the impact of IAS19 charges (pensions finance) . 

Average Cash Conversion over 3-years (Cash)

20%

The average of the adjusted Free Cash Flow divided by normalised Attributable Profit for each of the three years in the performance period. The adjusted Free Cash Flow is after maintaining the company's asset base ie operating cash flow minus capital expenditures, adjusted for exceptional items such as property gains or losses. 

Total Shareholder Return

25%

The total returns to shareholders which includes share price growth and ordinary dividend payments. The performance condition is measured against a comparator group consisting of the FTSE250 minus investment trusts.

Sustainability

25%

Achievement of 3 independent equally weighted Sustainability goals. 

TOTAL

100%

1. Subject to such adjustments as required by the Committee to ensure the performance condition fulfils its original intent. 

Performance Targets and Vesting Schedule

EPS CAGR (adjusted if necessary)

Threshold

Maximum

EPS CAGR in the period from 2025-2027. Measured from the 2024 base year

 

4%

12%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Average Cash Conversion

Threshold

Maximum

Average Cash Conversion over the period 2025 to 2027

 

70%

90%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Total Shareholder Return

Threshold

Maximum

Ranking Position vs FTSE250 (excluding investment trusts)

Median

Upper Quartile

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

Sustainability

Threshold

Maximum

Absolute reduction in Scope 1&2 emissions in tonnes from 2019 baseline

 

55%

65%

Absolute reduction in Scope 3 emissions in tonnes from 2019 baseline

 

22%

26%

Percentage of females in senior leadership roles

 

33%

37%

Vesting (The proportion of the award for this measure that vests)

25%

100%

 

There is a proportionate straight-line vesting for performance between each of the targets shown above. 

The range of performance targets have been set with reference to internal planning and external market expectations for the Company's future performance and are considered similarly challenging to the targets set in prior years allowing for current market conditions. The Committee would consider appropriate adjustments to the financial performance targets to extent the Company undertook material acquisitions or divestments, or share buybacks, during the period from 1 January 2025 to 31 December 2027.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBVORVKUOAAR
Date   Source Headline
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement
11th Nov 202211:01 amRNSHolding(s) in Company
11th Nov 20227:00 amRNSChange of Auditor
4th Nov 20227:00 amRNSDirectorate Change
19th Oct 20222:57 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSCapital Markets Day
5th Oct 20221:19 pmRNSBlock listing Interim Review
5th Oct 20221:10 pmRNSHolding(s) in Company
7th Sep 20221:52 pmRNSHolding(s) in Company
31st Aug 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20221:39 pmRNSTotal Voting Rights
25th Aug 202210:40 amRNSHolding(s) in Company
25th Aug 20227:00 amRNSDirectorate Change
24th Aug 20228:55 amRNSHolding(s) in Company
23rd Aug 20223:23 pmRNSDeal completion
16th Aug 20229:47 amRNSHolding(s) in Company
15th Aug 20229:53 amRNSDirector/PDMR Shareholding
12th Aug 20222:55 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSResults of Capital Raise
10th Aug 20224:37 pmRNSREX Retail Offer
10th Aug 20224:36 pmRNSProposed Capital Raise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.